- Home
- AFG vs RPRX Comparison
AFG vs RPRX Comparison
Compare AFG & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFG
- RPRX
- Stock Information
- Founded
- AFG 1872
- RPRX 1996
- Country
- AFG United States
- RPRX United States
- Employees
- AFG N/A
- RPRX N/A
- Industry
- AFG Property-Casualty Insurers
- RPRX Biotechnology: Pharmaceutical Preparations
- Sector
- AFG Finance
- RPRX Health Care
- Exchange
- AFG Nasdaq
- RPRX Nasdaq
- Market Cap
- AFG 11.4B
- RPRX 11.7B
- IPO Year
- AFG N/A
- RPRX 2020
- Fundamental
- Price
- AFG $137.97
- RPRX $24.92
- Analyst Decision
- AFG Buy
- RPRX Strong Buy
- Analyst Count
- AFG 4
- RPRX 6
- Target Price
- AFG $143.75
- RPRX $41.67
- AVG Volume (30 Days)
- AFG 446.7K
- RPRX 3.3M
- Earning Date
- AFG 02-04-2025
- RPRX 02-13-2025
- Dividend Yield
- AFG 2.14%
- RPRX 3.37%
- EPS Growth
- AFG 4.89
- RPRX 518.56
- EPS
- AFG 10.67
- RPRX 2.55
- Revenue
- AFG $7,916,000,000.00
- RPRX $2,266,003,000.00
- Revenue This Year
- AFG N/A
- RPRX $12.21
- Revenue Next Year
- AFG $7.22
- RPRX $11.13
- P/E Ratio
- AFG $12.84
- RPRX $9.76
- Revenue Growth
- AFG 8.28
- RPRX N/A
- 52 Week Low
- AFG $115.64
- RPRX $24.05
- 52 Week High
- AFG $150.19
- RPRX $31.66
- Technical
- Relative Strength Index (RSI)
- AFG 44.90
- RPRX 38.91
- Support Level
- AFG $134.57
- RPRX $24.05
- Resistance Level
- AFG $141.25
- RPRX $25.28
- Average True Range (ATR)
- AFG 2.73
- RPRX 0.52
- MACD
- AFG -0.99
- RPRX -0.09
- Stochastic Oscillator
- AFG 26.70
- RPRX 34.25
About AFG American Financial Group Inc.
American Financial Group Inc is a holding company that is engaged primarily in property and casualty insurance services. The company has a focus on specialized commercial products for businesses. The company also has annuity operations that are focused on sales of traditional fixed and fixed-indexed annuities in the education, bank, and individual markets. The company's insurance operations are conducted through the Great American Insurance Group. The group writes business in all 50 of the United States, primarily through independent agents and brokers.
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.